← Eichor
Study identifier: NCT05868616 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Non-Invasive Method for Evaluation of Cardiac Resynchronization Therapy

Condition: Heart Failure · Pacemaker DDD · Cardiomyopathies  ·  Sponsor: Oslo University Hospital

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Left bundle branch block (LBBB) exists in about 25% of patients with congestive heart failure and is associated with worsened prognosis. Cardiac resynchronization therapy (CRT) has been one of the most important advancements in the past two decades for patients with LBBB heart failure. However, 30-40% of patients receiving a CRT do not benefit from it. In this study, the investigators will test a noninvasive device to evaluate acute effect of CRT during implantation and at follow-up CRT controls. In addition, echocardiography will be performed during CRT turned ON and OFF to visualize the changes in intraventricular flow and functional parameters of the heart.

This description comes directly from the study's public registry record.

Talk to the study team

Espen W. Remme, Dr.ing  ·  004723071413  ·  espen.remme@medisin.uio.no

Marit Witsø, MD  ·  004723071402  ·  mhwitso@medisin.uio.no

Always discuss trial participation with your own doctor first.

Locations (1)

Oslo University HospitalOslo, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05868616